Table 5:
Creatinine clearance (mL/min/1.73 m2) |
||||
---|---|---|---|---|
≥80 | 50–80 | 30–50 | 15–30 | |
Operations with a low risk for bleeding | ||||
Dabigatran | ≥24 | ≥36 | ≥48 | Not indicated |
Rivaroxaban | ≥24 | ≥24 | ≥24 | ≥36 |
Edoxaban | ≥24 | ≥24 | ≥24 | ≥36 |
Abixaban | ≥24 | ≥24 | ≥24 | ≥36 |
Operations with a high risk for bleeding | ||||
Dabigatran | ≥48 | ≥72 | ≥96 | Not indicated |
Rivaroxaban | ≥48 | ≥48 | ≥48 | ≥48 |
Edoxaban | ≥48 | ≥48 | ≥48 | ≥48 |
Abixaban | ≥48 | ≥48 | ≥48 | ≥48 |